Making single-cell biology work

New collaboration between EMBL-EBI, the Wellcome Trust Sanger Institute and Fluidigm keeps research and technology on the cutting-edge of single-cell genomics

Making single-cell biology work

141217-singlecell2.jpgLuis Saraiva, EMBL-EBI
Single olfactory sensory neuron cell captured in the Fluidigm C1 system

A formal collaboration was announced today between the Wellcome Trust Sanger Institute, the European Bioinformatics Institute (EMBL-EBI) and Fluidigm Corporation to accelerate the development of new methods for the analysis of single-cell genomics data.

The Single Cell Genomics Centre (SCGC) on the Wellcome Trust Genome Campus will work with onsite Fluidigm senior staff to ensure that the centre has early access to the latest equipment, workflows and methods for genomics and proteomics research.

"Because we have early access to the most advanced technology, we can develop new experimental and computational methods that help us understand what is happening in each of our cells, at different points in the cell cycle. This is really a new frontier - we hope the work we do will help the technology mature more quickly, so that it can help more people find answers to complex biological questions."

Dr Sarah Teichmann of EMBL-EBI and the Sanger Institute

In addition to technology advancements, the collaboration will make single-cell research more accessible to the greater research community by developing and disseminating new workflows, bioinformatics tools, and data sets.

The collaboration builds on previous work between Fluidigm and founding members of the SCGC. For example, the Teichmann group discovered that immune cells produce steroids to regulate themselves - knowledge based on mRNA-seq data from single cells prepared by Fluidigm technology. Using single-cell gene expression data from Fluidigm's C1TM Single-Cell Auto Prep system and sequencing technology, John Marioni's group at EMBL-EBI developed a novel statistical method that shows how single-cell mRNA sequencing can be used to pinpoint true differences between cells in apparently homogeneous samples. Thierry Voet, based at KU Leuven and an associate member of Faculty at the Sanger Institute, uses DNA sequencing at the single-cell level to understand how spontaneous variations in DNA can arise as cells divide.

"Our work with the SCGC is about co-creating a solid foundation for a revolution in biological understanding that will come from single-cell analysis. Together, we can build better informatics tools to extract relevant biology from the massive amounts of single-cell RNA expression data that our systems generate. We'll also find innovative ways to determine the DNA, protein, RNA, and epigenetic state of each cell and to scale the process up to perform across thousands and millions of cells."

Robert C Jones, Fluidigm Executive Vice President of Research and Development

These high-throughput techniques allow researchers to explore cellular heterogeneity in normal development and in disease at the single-cell level, offering a vast improvement over the current practice of investigating millions of cells in bulk. Until now, scientists have been limited in their ability to identify functionally distinct subpopulations of cells and understand their contribution into the development of diseases such as cancer. DNA-seq and RNA-seq techniques are opening up new opportunities to discover and explore the diverse nature of cells at the highest possible resolution.

Notes to Editors
Publications
  • Single-cell RNA sequencing reveals T helper cells synthesizing steroids de novo to contribute to immune homeostasis.

    Mahata B, Zhang X, Kolodziejczyk AA, Proserpio V, Haim-Vilmovsky L et al.

    Cell reports 2014;7;4;1130-42

  • Accounting for technical noise in single-cell RNA-seq experiments.

    Brennecke P, Anders S, Kim JK, Kołodziejczyk AA, Zhang X et al.

    Nature methods 2013;10;11;1093-5

  • Single-cell paired-end genome sequencing reveals structural variation per cell cycle.

    Voet T, Kumar P, Van Loo P, Cooke SL, Marshall J et al.

    Nucleic acids research 2013;41;12;6119-38

Fluidigm Technology

The Single-Cell Genomics Centre employs Fluidigm's C1 Single-Cell Auto Prep and BiomarkTM HD systems, and has access to Fluidigm's CyTOF® mass spectrometry technology as well.

Selected Websites
Contact the Press Office

Emily Mobley, Media Manager

Tel +44 (0)1223 496 851

Dr Samantha Wynne, Media Officer

Tel +44 (0)1223 492 368

Dr Matthew Midgley, Media Officer

Tel +44 (0)1223 494 856

Wellcome Sanger Institute,
Hinxton,
Cambridgeshire,
CB10 1SA,
UK

Mobile +44 (0) 7748 379849

Recent News

New malaria drug targets identified in liver stage of life cycle
Hope that new liver-stage drugs will help to counter the threat of antimicrobial resistance to current blood-stage medicines
Ambitious project to map genomes of all life on British Isles funded by Wellcome
An unprecedented insight to the diverse range of species on the British Isles will be made possible by Wellcome funding to the Darwin Tree of Life Project
Measles infection wipes our immune system's memory, leaving us vulnerable to other diseases
Research explains why children often catch other infections after measles, and highlights the importance of vaccination